Biopharmaceutical Fermentation Systems Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026
NEW YORK, August 8, 2018 /PRNewswire/ -- Global Biopharmaceutical Fermentation Systems Market: Overview
This report analyzes the global biopharmaceutical fermentation systems market in terms of its current and future scenario.Microbial cell systems have been in use for biopharmaceutical production since the introduction of recombinant insulin.
Read the full report: https://www.reportlinker.com/p05482738
Ease of gene translation and bioproduction process has contributed to the significant adoption of microbial systems in biopharmaceutical production. Rise in research and development activities, technological advancements, increase in awareness about products, and new product launches are some of the factors likely to drive the biopharmaceutical fermentation systems market in the near future.
This report on the global biopharmaceutical fermentation systems market comprises an elaborate executive summary, including a market snapshot that provides information about various segments of the market.The report also provides information and data analysis of the global market with respect to its segments based on product, application, end-user, and geography.
A detailed qualitative analysis of drivers, restraints, and opportunities of the market has been provided in the market overview section.In addition, the section comprises a competitive matrix and company profiles with a business overview to project the competitive landscape of the market.
It also provides market attractiveness analysis in terms of geography, and market share analysis by key players, thereby presenting a thorough analysis of the overall competitive scenario prevailing in the biopharmaceutical fermentation systems market.
Global Biopharmaceutical Fermentation Systems Market: Key Segments
Based on product, the global biopharmaceutical fermentation systems market has been segmented into upstream products ( fermenters, bioprocess analyzers, process monitoring devices, culture & media preparation, culture media, buffers & inducers, other upstream products) and downstream products (filtration & separation systems, chromatography, consumables & accessories, and other downstream products).In terms of application, the market has been classified into recombinant proteins, monoclonal antibodies, antibiotics, probiotics, and others.
Based on end-user, the market has been segmented into biopharmaceutical companies, contract manufacturing organizations, contract research organizations, academic research institutes, food industry, and others.The global biopharmaceutical fermentation systems market has been analyzed based on technology trends, expenditure on emerging technologies, and presence of key players in the region.
Market size and forecast for each of these segments have been provided for the period of 2016 to 2026, along with their respective CAGR for the forecast period from 2018 to 2026, considering 2017 as the base year.
Global Biopharmaceutical Fermentation Systems Market: Regional Outlook
In terms of region, the global biopharmaceutical fermentation systems market has been categorized into five major regions and key countries in these regions: North America (the U.S., Canada), Europe (the U.K., Germany, France, Italy, Spain, and Rest of Europe), Asia Pacific (China, India, Japan, Australia & New Zealand, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and Middle East & Africa (GCC, South Africa, Israel, and Rest of Middle East & Africa). Market size and forecast for each of these regions and their key countries have been provided for the period from 2016 to 2026, along with their respective CAGR for the forecast period 2018-2026, considering 2017 as the base year. This report also covers the competitive scenario of the market in these regions.
Companies Mentioned in Report
The report profiles major players operating in the global biopharmaceutical fermentation systems market in terms of attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments. Major companies profiled in this report are GE Healthcare, Thermo Fisher Scientific Inc., Danaher Corporation, Sartorius StedimBiotech, Merck KGaA, Eppendorf AG, F. Hoffmann-La Roche Ltd., Nova Biomedicals, Lonza, and Becton, and Dickinson and Company.
The global biopharmaceutical fermentation systems market has been segmented as follows:
Biopharmaceutical Fermentation Systems Market, by Product
Upstream Products
Fermenters
Bioprocess Analyzers
Process Monitoring Devices
Culture & Media Preparation
Culture Media, Buffers & Inducers
Other Upstream Products
Downstream Products
Filtration & Separation Systems
Chromatography
Consumables & Accessories
Other Downstream Products
Biopharmaceutical Fermentation Systems Market, by Application
Recombinant Proteins
Monoclonal Antibodies
Antibiotics
Probiotics
Others (Amino Acids, Enzymes, Polysaccharides, etc.)
Biopharmaceutical Fermentation Systems Market, by End-user
Biopharmaceutical Companies
Contract Manufacturing Organizations
Contract Research Organizations
Academic Research Institutes
Food Industry
Others
Biopharmaceutical Fermentation Systems Market, by Geography
North America
U.S.
Canada
Europe
Germany
U.K.
France
Italy
Spain
Rest of Europe
Asia Pacific
China
Japan
Australia & New Zealand
India
Rest of Asia Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle East & Africa
GCC
South Africa
Israel
Rest of Middle East & Africa
Read the full report: https://www.reportlinker.com/p05482738
About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.
__________________________
Contact Clare: [email protected]
US: (339)-368-6001
Intl: +1 339-368-6001
SOURCE Reportlinker
Share this article